摘要
背景:心血管疾病(CVD)是全球最常见的死亡原因,约占全世界死亡人数的30%。高血压是心血管疾病发病率和死亡率的常见因素。 方法和结果:脑血管病患者血浆铬粒素A(CGA)浓度升高,已建立的原发性高血压和心力衰竭(HF)患者血浆铬粒素A(CGA)浓度升高。连体在人原发性高血压中,CGA衍生肽的血浆水平(CST)降低。 CGA-TO-CST的低转换与患者死亡率升高有关急性心衰住院。与人类发现一致的是,cga基因敲除(chga-ko)小鼠缺乏cst,导致高血压的发展和补充cst对chga-ko小鼠的休息。矿石血压,暗示CST在调节高血压的关键作用。在外周系统中,CST通过刺激组胺释放,抑制儿茶酚胺分泌来降低血压。或引起血管扩张。中枢,CST通过刺激延髓尾侧腹外侧区(CVLM)和pyrami的GABA能神经元,改善压力反射敏感性(BRS)和心率变异性(HRV)。中央杏仁核的Dal神经元; CST还通过激发谷氨酸能延髓腹外侧延髓(RVLM)神经元减少BRS。 此外,CST通过抑制各向同性而提供心脏保护。D类软体动物;激活线粒体KATP通道,刺激再灌注损伤挽救激酶(Risk)和Survivin激活因子增强(安全)通路,从而抑制MI。线粒体渗透性过渡孔(MPTP)。cst通过直接抑制Ca2+/钙调素依赖性蛋白激酶Ⅱδ(CaMKIIδ)的活性及其还原作用来调节心肌细胞的Ca2+水平。N参与磷酸化磷脂和ryanodine受体2,从而为CST在衰竭心肌中的直接功能作用提供支持。 结论:这些多重效应使CST成为心血管功能的主要调节者。
关键词: 铬粒素A,肾上腺素能β-2受体,心肌病,心脏保护,心力衰竭,高血压,免疫细胞,烟碱-胆碱能受体。
Current Medicinal Chemistry
Title:Catestatin: A Master Regulator of Cardiovascular Functions
Volume: 25 Issue: 11
关键词: 铬粒素A,肾上腺素能β-2受体,心肌病,心脏保护,心力衰竭,高血压,免疫细胞,烟碱-胆碱能受体。
摘要: Background: Cardiovascular disease (CVD), the most common cause of death globally, accounts for ~30% of all deaths worldwide. Hypertension is a common contributor to morbidity and mortality from CVD.
Methods and Results: The plasma concentration of chromogranin A (CgA) is elevated in patients with CVD as well as patients with established human essential hypertension and heart failure (HF). In contrast, the plasma level of the CgA-derived peptide catestatin (CST) is diminished in human essential hypertension. Low conversion of CgA-to-CST has been associated with increased mortality in patients hospitalized with acute HF. Consistent with human findings, the lack of CST in CgA knockout (Chga-KO) mice eventuates in the development of hypertension and supplementation of CST to Chga-KO mice restores blood pressure, implicating CST as a key player in regulating hypertension. In the peripheral system, CST decreases blood pressure by stimulating histamine release, inhibiting catecholamine secretion, or causing vasodilation. Centrally, CST improves baroreflex sensitivity (BRS) and heart rate variability (HRV) by exciting GABAergic neurons in the caudal ventrolateral medulla (CVLM) and pyramidal neurons of the central amygdala; CST also decreases BRS by exciting glutamatergic rostral ventrolateral medulla (RVLM) neurons. In addition, CST provides cardioprotection by inhibiting inotropy and lusitropy; activating mitochondrial KATP channels, and stimulating reperfusion injury salvage kinase (RISK) and survivor activating factor enhancement (SAFE) pathways and consequent inhibition of mitochondrial permeability transition pore (mPTP). CST modulates cardiomyocyte Ca2+ levels by direct inhibition of Ca2+/calmodulin-dependent protein kinase IIδ (CaMKIIδ) activity and consequent reduction in phosphorylation of phospholamban and ryanodine receptor 2, thereby providing support for a direct functional role of CST in the failing myocardium.
Conclusion: These multitude of effects establish CST as a master regulator of cardiovascular functions.
Export Options
About this article
Cite this article as:
Catestatin: A Master Regulator of Cardiovascular Functions, Current Medicinal Chemistry 2018; 25 (11) . https://dx.doi.org/10.2174/0929867324666170425100416
DOI https://dx.doi.org/10.2174/0929867324666170425100416 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Editorial [Hot Topic Management of Perioperative Systemic Inflammation During Cardiopulmonary Bypass: We Need a Multimodal Approach (Guest Editor: David Faraoni)]
Recent Patents on Cardiovascular Drug Discovery Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Usefulness of Contrast-enhanced Ultrasound in the Evaluation of Chronic Kidney Disease
Current Medical Imaging Heme Oxygenase-1: A Novel Therapeutic Target in Oxidative Tissue Injuries
Current Medicinal Chemistry Endothelial Endocytic Pathways: Gates for Vascular Drug Delivery
Current Vascular Pharmacology New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways
Current Topics in Medicinal Chemistry Inflammation in Ischemic Stroke: Mechanisms, Consequences and Possible Drug Targets
CNS & Neurological Disorders - Drug Targets Augmentation of Creatine in the Heart
Mini-Reviews in Medicinal Chemistry Subject Index to Volume 2
Current Vascular Pharmacology Thrombolytic Therapy in Acute Ischemic Stroke - Basic Concepts
Current Vascular Pharmacology Prophylactic Neuroprotection
Current Drug Targets Future Perspectives on the Fibrinolytic Therapy of Intracerebral Hemorrhages
Central Nervous System Agents in Medicinal Chemistry Acute Kidney Injury: Turning the Tide
Current Drug Targets Role of Resveratrol in Modulating microRNAs in Human Diseases: From Cancer to Inflammatory Disorder
Current Medicinal Chemistry Preface:
CNS & Neurological Disorders - Drug Targets Microglial Integrity is Maintained by Erythropoietin Through Integration of Akt and Its Substrates of lycogen Synthase Kinase-3β, β-Catenin, and Nuclear Factor-κB
Current Neurovascular Research Does Caffeine Affect Cardiovascular Responses?
Vascular Disease Prevention (Discontinued) Perinatal Brain Injury
Current Pediatric Reviews Preface [Hot topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
Current Pharmaceutical Design Sulfur Dioxide: a Novel Gaseous Signal in the Regulation of Cardiovascular Functions
Mini-Reviews in Medicinal Chemistry